PAX8 and metastatic malignant neoplasm in the lymph nodes: Sangoi et al found that PAX8 was positive in 74% of primary pancreatic neuroendocrine tumors and PAX8 expression did not correlate with World Health Organization categorization, grade, size, functional status or the presence of liver or lymph node metastases (22).